Evidence map›Paper›PMID 16261167›Full record

Trial reportMolecular psychiatry2006

Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

T A Greenwood, N J Schork, E Eskin, J R Kelsoe

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Molecular psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Methylation in the Promoter Region of the Dopamine TransporterInternational journal of environmental research and public health · 2022
    Article
  12. Article
  13. Influence ofGenes · 2021
    Article
  14. Evaluating endophenotypes for bipolar disorder.International journal of bipolar disorders · 2021
    Review
  15. Article
  16. Article
  17. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
    Article
  18. Review
  19. Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

T A GreenwoodDepartment of Psychiatry, University of California at San Diego, and San Diego VA Health Care System, La Jolla, CA 92093, USA.
N J Schork
E Eskin
J R Kelsoe
University of California, San Diego · US

Funding

ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
Genomic studies of bipolar disorder and chromosome 22R01MH068503 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KELSOE, JOHN R. · 2004 to 2008
$3.1M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH059567 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KELSOE, JOHN R. · 1998 to 2007
$1.8M
Microarray studies of amphetamine models of psychosisR01DA013769 · NIDA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI KELSOE, JOHN R · 2001 to 2003
$1.1M
DIAGNOSTIC CENTER FOR LINKAGE STUDIES IN BIPOLAR ILLNESSU01MH046282 · NIMH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI NURNBERGER, JOHN I · 1989 to 1997
–
GENETIC LINKAGE STUDIES OF BIPOLAR AFFECTIVE DISORDERR29MH047612 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI KELSOE, JOHN R · 1992 to 1996
–
DIAGNOSTIC CENTERS FOR PSYCHIATRY LINKAGE STUDIESU01MH046274 · NIMH · JOHNS HOPKINS UNIVERSITY · PI DEPAULO, J RAYMOND · 1989 to 1996
–
DIAGNOSTIC CTR FOR LINKAGE STUDIES OF BIPOLAR DISORDERU01MH046280 · NIMH · WASHINGTON UNIVERSITY · PI REICH, THEODORE · 1989 to 1997
–
Intramural NIH HHSNCRR NIH HHS M01 RR00827NIDA NIH HHS DA13769NIMH NIH HHS MH47612NIMH NIH HHS MH59567NIMH NIH HHS MH68503NIMH NIH HHS UO1 MH46274NIMH NIH HHS UO1 MH46280NIMH NIH HHS UO1 MH46282
6 · The paper itself

Abstract

The dopamine transporter (DAT) is the site of action of stimulants, and variations in the human DAT gene (DAT1) have been associated with susceptibility to several psychiatric disorders including attention deficit hyperactivity disorder (ADHD) and bipolar disorder. We have previously reported the association of bipolar disorder to novel SNPs in the 3' end of DAT1. We now report the identification of 20 additional SNPs in DAT1 for a total of 63 variants. We also report evidence for association to bipolar disorder in a second independent sample of families. Eight newly identified SNPs and 14 previously identified SNPs were analyzed in two independent samples of 50 and 70 families each using the transmission disequilibrium test. Two of the eight new SNPs, one in intron 8 and one in intron 13, were found to be moderately associated with bipolar disorder, each in one of the two independent samples. Analysis of haplotypes comprised of all 22 SNPs in sliding windows of five adjacent SNPs revealed an association to the region near introns 7 and 8 in both samples (empirical P-values 0.002 and 0.001, respectively, for the same window). The haplotype block structure observed in the gene in our previous study was confirmed in this sample with greater resolution allowing for discrimination of a third haplotype block in the middle of the gene. Together, these data are consistent with the presence of multiple variants in DAT1 that convey susceptibility to bipolar disorder.

Indexed as

Bipolar DisorderDopamine Plasma Membrane Transport ProteinsFemaleGenetic MarkersGenetic Predisposition to DiseaseHaplotypesHumansLinkage DisequilibriumMaleMinisatellite RepeatsPedigreePolymorphism, Single NucleotideDopamine Plasma Membrane Transport ProteinsGenetic MarkersSLC6A3 protein, human

Identifiers

PMID16261167
OpenAlexW2077135956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.